{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:54:14Z","timestamp":1787064854293,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000989"],"award-info":[{"award-number":["32000989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972368"],"award-info":[{"award-number":["81972368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002695"],"award-info":[{"award-number":["82002695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M670051ZX"],"award-info":[{"award-number":["2020M670051ZX"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M682911"],"award-info":[{"award-number":["2020M682911"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0906003"],"award-info":[{"award-number":["2019YFA0906003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.scib.2023.11.027","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T19:34:21Z","timestamp":1699990461000},"page":"3207-3224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Engineering redirected NF-\u03baB\/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer"],"prefix":"10.1016","volume":"68","author":[{"given":"Binbin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liman","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiren","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2023.11.027_b0005","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.scib.2023.11.027_b0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12935-022-02624-9","article-title":"Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine","volume":"22","author":"Dhyani","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.scib.2023.11.027_b0015","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1158\/0008-5472.CAN-15-2104","article-title":"Cell cycle\u2013dependent mechanisms underlie vincristine-induced death of primary acute lymphoblastic leukemia cells","volume":"76","author":"Kothari","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.scib.2023.11.027_b0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/jcs.03390","article-title":"Lap2\u03b1-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit","volume":"120","author":"Naetar","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.scib.2023.11.027_b0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/neuonc\/noy037","article-title":"Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling","volume":"20","author":"He","year":"2018","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.scib.2023.11.027_b0030","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.7150\/jca.27381","article-title":"OIP5 promotes growth, metastasis and chemoresistance to cisplatin in bladder cancer cells","volume":"9","author":"Wang","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.scib.2023.11.027_b0035","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00432-017-2485-4","article-title":"Opa interacting protein 5 acts as an oncogene in bladder cancer","volume":"143","author":"He","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.scib.2023.11.027_b0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1349-7006.2011.02167.x","article-title":"Characterization of an opa interacting protein 5 involved in lung and esophageal carcinogenesis","volume":"103","author":"Koinuma","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.scib.2023.11.027_b0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.scib.2023.11.027_b0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a better understanding of the complexity of cancer drug resistance","volume":"56","author":"Gottesman","year":"2016","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.scib.2023.11.027_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: an update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.scib.2023.11.027_b0060","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/acs.chemrev.0c00383","article-title":"Challenges and opportunities in cancer drug resistance","volume":"121","author":"Ward","year":"2020","journal-title":"Chem Rev"},{"key":"10.1016\/j.scib.2023.11.027_b0065","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.scib.2020.12.017","article-title":"Induction of core symptoms of autism spectrum disorder by in vivo CRISPR\/Cas9-based gene editing in the brain of adolescent rhesus monkeys","volume":"66","author":"Wu","year":"2021","journal-title":"Sci Bull"},{"key":"10.1016\/j.scib.2023.11.027_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.scib.2023.11.027_b0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","article-title":"Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer","volume":"22","author":"Labrie","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.scib.2023.11.027_b0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","article-title":"CRISPR in cancer biology and therapy","volume":"22","author":"Katti","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.scib.2023.11.027_b0085","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.scib.2021.01.027","article-title":"MAFG-AS1\/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis","volume":"66","author":"Xiang","year":"2021","journal-title":"Sci Bull"},{"key":"10.1016\/j.scib.2023.11.027_b0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41576-021-00436-7","article-title":"Engineering synthetic RNA devices for cell control","volume":"23","author":"Dykstra","year":"2022","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.scib.2023.11.027_b0095","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.scib.2019.07.035","article-title":"Engineering nucleic acid chemistry for precise and controllable CRISPR\/Cas9 genome editing","volume":"64","author":"Cai","year":"2019","journal-title":"Sci Bull"},{"key":"10.1016\/j.scib.2023.11.027_b0100","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nmeth.3994","article-title":"Directing cellular information flow via CRISPR signal conductors","volume":"13","author":"Liu","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.scib.2023.11.027_b0105","doi-asserted-by":"crossref","first-page":"15939","DOI":"10.1038\/ncomms15939","article-title":"Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation","volume":"8","author":"Tang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2023.11.027_b0110","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-019-09985-2","article-title":"Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs","volume":"10","author":"Kundert","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2023.11.027_b0115","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1021\/jacs.2c10545","article-title":"Orthogonal chemical activation of enzyme-inducible CRISPR\/Cas9 for cell-selective genome editing","volume":"144","author":"Cai","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2023.11.027_b0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2018.02.011","article-title":"NF-\u03baB in pancreatic cancer: its key role in chemoresistance","volume":"421","author":"Li","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.scib.2023.11.027_b0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.apsb.2017.09.008","article-title":"Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma","volume":"8","author":"Ruan","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.scib.2023.11.027_b0130","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1039\/c3cc38397k","article-title":"Human serum albumin (HSA) nanoparticles stabilized with intermolecular disulfide bonds","volume":"49","author":"Wang","year":"2013","journal-title":"Chem Commun"},{"key":"10.1016\/j.scib.2023.11.027_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101411","article-title":"Human lung adenocarcinoma-derived organoid models for drug screening","volume":"23","author":"Li","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.scib.2023.11.027_b0140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41477-020-0704-5","article-title":"Highly efficient DNA-free plant genome editing using virally delivered CRISPR\u2013Cas9","volume":"6","author":"Ma","year":"2020","journal-title":"Nat Plants"},{"key":"10.1016\/j.scib.2023.11.027_b0145","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.scib.2023.11.027_b0150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1261\/rna.878908","article-title":"Selection and characterization of anti-NF-\u03baB p65 RNA aptamers","volume":"14","author":"Wurster","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.scib.2023.11.027_b0155","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1021\/acs.molpharmaceut.9b00184","article-title":"Targeting delivery of oligodeoxynucleotides to macrophages by mannosylated cationic albumin for immune stimulation in cancer treatment","volume":"16","author":"Ai","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.scib.2023.11.027_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2018.12.005","article-title":"Simultaneous quantification of the degree of hydrolysis, protein conversion rate and mean molar weight of peptides released in the course of enzymatic proteolysis","volume":"1105","author":"Beaubier","year":"2018","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.scib.2023.11.027_b0165","doi-asserted-by":"crossref","first-page":"1901437","DOI":"10.1002\/adfm.201901437","article-title":"Bacterium-mimicking vector with enhanced adjuvanticity for cancer immunotherapy and minimized toxicity","volume":"29","author":"Zheng","year":"2019","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.scib.2023.11.027_b0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"Star: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.scib.2023.11.027_b0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: Accurate transcript quantification from RNA-seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.scib.2023.11.027_b0180","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.scib.2023.11.027_b0185","article-title":"Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.scib.2023.11.027_b0190","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/14737140.3.6.793","article-title":"Antitumor effect of a novel nuclear factor-\u03baB activation inhibitor in bladder cancer cells","volume":"3","author":"Horiguchi","year":"2003","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.scib.2023.11.027_b0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.leukres.2015.01.016","article-title":"Overexpression of survivin via activation of ERK1\/2, Akt, and NF-\u03baB plays a central role in vincristine resistance in multiple myeloma cells","volume":"39","author":"Tsubaki","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.scib.2023.11.027_b0200","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1038\/sj.onc.1208842","article-title":"Betulinic acid as new activator of NF-\u03baB: molecular mechanisms and implications for cancer therapy","volume":"24","author":"Kasperczyk","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.scib.2023.11.027_b0205","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40360-020-00432-3","article-title":"Dehydroxymethylepoxyquinomicin, a novel nuclear factor-\u03baB inhibitor, prevents the development of cyclosporine a nephrotoxicity in a rat model","volume":"21","author":"Morita","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.scib.2023.11.027_b0210","doi-asserted-by":"crossref","first-page":"eabc9450","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.scib.2023.11.027_b0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"10.1016\/j.scib.2023.11.027_b0220","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1021\/acs.molpharmaceut.9b00704","article-title":"Anti-CD133 antibody-targeted therapeutic immunomagnetic albumin microbeads loaded with vincristine-assisted to enhance anti-glioblastoma treatment","volume":"16","author":"Wang","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.scib.2023.11.027_b0225","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/pharmaceutics11110608","article-title":"An effective cationic human serum albumin-based gene-delivery carrier containing the nuclear localization signal","volume":"11","author":"Guan","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.scib.2023.11.027_b0230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2017.07.021","article-title":"Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration","volume":"115","author":"Zhou","year":"2017","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.scib.2023.11.027_b0235","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt.4005","article-title":"Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing","volume":"35","author":"Yin","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.scib.2023.11.027_b0240","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1021\/acsbiomaterials.0c00073","article-title":"PH\/GSH-dual-sensitive hollow mesoporous silica nanoparticle-based drug delivery system for targeted cancer therapy","volume":"6","author":"Chen","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.scib.2023.11.027_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.124450","article-title":"Tumor environment responsive degradable CuS@ mSiO2@ MnO2\/DOX for MRI guided synergistic chemo-photothermal therapy and chemodynamic therapy","volume":"389","author":"Zhang","year":"2020","journal-title":"Chem Eng J"},{"key":"10.1016\/j.scib.2023.11.027_b0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acsnano.6b04261","article-title":"Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.scib.2023.11.027_b0255","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jconrel.2022.05.063","article-title":"Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation","volume":"350","author":"Takakura","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.scib.2023.11.027_b0260","first-page":"97","article-title":"Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method","volume":"6","author":"Zhang","year":"2016","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.scib.2023.11.027_b0265","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.scib.2023.11.027_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100712","article-title":"Inhibiting the inhibitors: targeting anti-apoptotic proteins in cancer and therapy resistance","volume":"52","author":"Shahar","year":"2020","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.scib.2023.11.027_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112028","article-title":"Design and synthesis of \u03b1-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP) 1B1-mediated drug resistance via targeted CYP1B1 degradation","volume":"189","author":"Zhou","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.scib.2023.11.027_b0280","doi-asserted-by":"crossref","first-page":"0162","DOI":"10.34133\/research.0162","article-title":"OIP5 interacts with NCK2 to mediate human spermatogonial stem cell self-renewal and apoptosis through cell cyclins and cycle progression and its abnormality is correlated with male infertility","volume":"6","author":"Cui","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.scib.2023.11.027_b0285","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-\u03baB: blending metabolism, immunity, and inflammation","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.scib.2023.11.027_b0290","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/sj.onc.1204343","article-title":"Inhibition of the NF-\u03baB transcription factor increases BAX expression in cancer cell lines","volume":"20","author":"Bentires-Alj","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.scib.2023.11.027_b0295","doi-asserted-by":"crossref","first-page":"19416","DOI":"10.1021\/acsami.8b03823","article-title":"Photoresponsive nanovehicle for two independent wavelength light-triggered sequential release of P-gp shRNA and doxorubicin to optimize and enhance synergistic therapy of multidrug-resistant cancer","volume":"10","author":"Wu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.scib.2023.11.027_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100914","article-title":"Stimulus-responsive sequential release systems for drug and gene delivery","volume":"34","author":"Ahmadi","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.scib.2023.11.027_b0305","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41419-020-2399-y","article-title":"Life, death, and autophagy in cancer: NF-\u03baB turns up everywhere","volume":"11","author":"Verzella","year":"2020","journal-title":"Cell Death Dis"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927323007818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927323007818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:57:53Z","timestamp":1761868673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927323007818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":61,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2095927323007818"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2023.11.027","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering redirected NF-\u03baB\/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2023.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Science China Press. Published by Elsevier B.V. and Science China Press.","name":"copyright","label":"Copyright"}]}}